UFT plus carboplatin for head and neck cancer

Cisplatin plus fluorouracil (5-FU) is widely accepted as neoadjuvant and adjuvant chemotherapy in the treatment of head and neck squamous cell carcinoma; UFT is also an active agent against this disease. In the first retrospective study, we examined the efficacy of UFT as adjuvant chemotherapy in pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology (Williston Park, N.Y.) N.Y.), 2000-10, Vol.14 (10 Suppl 9), p.72
Hauptverfasser:	Fujii, M, Ohno, Y, Tokumaru, Y, Imanishi, Y, Kanke, M, Tomita, T, Yamashita, T
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Antineoplastic Agents - administration & dosage Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Carboplatin - administration & dosage Carboplatin - therapeutic use Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - pathology Chemotherapy, Adjuvant Drug Therapy, Combination Humans Maxillary Sinus Neoplasms - drug therapy Maxillary Sinus Neoplasms - pathology Survival Analysis Tegafur - administration & dosage Treatment Outcome Uracil - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!